Join the discussion about health care issues in our nation and community on our blog, WakeMed Voices.

Manage Your Health

Share/Save/Bookmark
Decrease (-) Restore Default Increase (+)

Manage Your Health

Back to Health Library   Print This Page Print    Email to a Friend Email
    Nitroblue tetrazolium test
   
Nitroblue tetrazolium test

Nitroblue tetrazolium test is a blood test that measures the ability of the immune system to convert the colorless nitroblue tetrazolium (NBT) to a deep blue. This test is performed as a screen for chronic granulomatous disease (CGD). If an individual has CGD, the white cells in their blood will not turn blue when exposed to the NBT.


Review Date: 2/12/2009
Reviewed By: William McGee, M.D., M.H.A., Director, ICU Quality Improvement Critical Care Division, Baystate Medical Center, and Associate Professor of Medicine, Tufts University School of Medicine, Boston, MA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
 
© WakeMed Health & Hospitals, Raleigh, NC  |  919.350.8000  |